Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001012975-15-000595
Filing Date
2015-08-11
Accepted
2015-08-11 20:26:59
Documents
1
Period of Report
2015-08-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 6527
  Complete submission text file 0001012975-15-000595.txt   7877
Mailing Address 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
STARR KEVIN P (Reporting) CIK: 0001192603 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37539 | Film No.: 151045310

Mailing Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Issuer) CIK: 0001629137 (see all company filings)

EIN.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations